Document Detail

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.
MedLine Citation:
PMID:  23283648     Owner:  NLM     Status:  In-Data-Review    
The aim of our study was to assess the predictive value of platelet/lymphocyte ratio (PLR) and neutrophil/lymphocyte ratio (NLR) in terms of survival in breast cancer patients. This is an observational study of 437 breast cancer patients treated between January 2004 and December 2006. Survival status was obtained from our cancer registry and Social Security Death Index. Survival analysis, stratified by NLR and PLR quartiles, was used to evaluate their prognostic values. Patients in the highest 4th PLR and NLR quartiles had higher 5-year mortality rate (30.4 and 40.3 %) compared to those in the lower three PLR and NLR quartiles (12.1 and 8.2 %), p < 0.0001. Multivariate hazard ratios of 4th PLR and NLR quartiles compared to first PLR and NLR quartiles were 3.68 (1.74-7.77, p = 0.001) and 3.67 (1.52-8.86, p = 0.004). Higher PLR only showed a trend of higher mortality in patients with normal lymphocyte count, whereas NLR continued to be statistically significant predictor of 5-year mortality in all lymphocyte count subsets. Pretreatment NLR is an independent predictor of long-term mortality in breast cancer patients, whereas pretreatment PLR was not superior to absolute lymphocyte count alone in predicting long-term mortality.
Basem Azab; Neeraj Shah; Jared Radbel; Pamela Tan; Vijaya Bhatt; Steven Vonfrolio; Ayman Habeshy; Antonio Picon; Scott Bloom
Related Documents :
10490058 - Skin cancer screening by australian family physicians: variation with physician beliefs...
23551358 - Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of...
17852718 - Chronic mucocutaneous candidiasis and oesophageal cancer.
2563048 - Human papilloma virus infection and skin cancer in renal allograft recipients.
9286298 - Long-term survivors of childhood cancer. the medical consequences of cure.
12429148 - Fluorescence detection of bladder cancer: a review.
Publication Detail:
Type:  Journal Article     Date:  2013-01-03
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  432     Citation Subset:  IM    
Department of Surgery, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY, 10305, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Electrophysiological response of chicken's jejunal epithelium to increasing levels of T-2 toxin.
Next Document:  Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: singl...